Chemical Structure (Relpax 01)
Relpax
Product Images NDC 0049-2330
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Relpax (NDC 0049-2330). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Roerig, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Relpax 02)
The text is describing a graph shown in Figure 1. The graph displays the estimated probability of initial headache response within 2 hours, measured in hours on the x-axis and the estimated probability on the y-axis. The text includes three types of Eletriptan dosages: 20mg, 40mg, and 80mg. The rest of the text seems to be unreadable output.*
Figure 2 (Relpax 03)
This is a figure showing the estimated probability of taking a second dose or other medication within the 24 hours following the first dose. The x-axis represents the time from the initial dose in hours, while the y-axis represents the probability percentage. Some medications are labeled on the graph as "T3 MEERO LGRS 22 2 HETRET (20ME)", "5-G-0 ELETRIPTAN (40 NG)", and "ELETRIPTAN (80 WG)".*
Logo (Relpax 04)
This is a statement that the product in question is being distributed by Roerig, which is a division of Pfizer Inc located in New York City with the zip code 10017.*
Logo (Relpax 05)
This text indicates that a company called Roerig, which is a division of Pfizer Inc located in NY, NY 10017, is responsible for distributing a certain product or products.*
Principal Display Panel (20 mg Tablet Blister Pack)
This is a medication sheet for Relpax 20mg (eletriptan HBr) tablets manufactured by Pfizer Inc. It provides instructions on how to remove the pills from the foil packaging. Lot numbers and expiration dates are also mentioned on the sheet.*
Principal Display Panel (20 mg Tablet Blister Pack Carton)
This is a medication called RELPAX, containing eletriptan hydrobromide tablets used for treating migraines. It is advised to be stored at temperatures ranging from 20°C to 25°C (B8°F to 77°F). Each tablet contains elefrptan hydrcbromide equalert fo 20 mg eltriptan. The product is made in Ireland, and the USP Controlled Room Temperature mentions using precautions while handling. The instructional manual is mentioned to guide the usage of the medicine. The NDC number is 0049-2330-45. The GTIN number is 0300492330457.*
Principal Display Panel (40 mg Tablet Blister Pack)
The text is related to a medication called Relpax 40 mg. It contains Eletriptan HBr and is manufactured by Pfizer Inc. The text contains instructions on how to remove the tablet along with a lot and expiry date.*
Principal Display Panel (40 mg Tablet Blister Pack Carton)
This is a prescription drug called RELPAX. It contains eletriptan HBr, equivalent to 40 mg eletriptan per tablet. It is used for excursions between 23-30°C (73-86°F) and stored at controlled room temperature. Dosage information is enclosed in the prescribing information. It comes in a box containing one card with six mg tablets. The NDC number is 0049-2340-45.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
